Outlook Therapeutics, Inc.
OTLK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$20 | -$46 | $17 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $2 | $2 | $4 |
| Change in WC | – | $2 | -$6 | $7 |
| Other Non-Cash | – | $4 | $34 | -$39 |
| Operating Cash Flow | – | -$12 | -$17 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$1 | $0 | $0 |
| Stock Issued | – | $14 | $1 | $2 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $17 | $0 |
| Financing Cash Flow | – | $13 | $18 | $2 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | $1 | $2 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $8 | $6 | $15 |
| End Cash | – | $9 | $8 | $6 |
| Free Cash Flow | – | -$12 | -$17 | -$11 |